|
|
Volumn 38, Issue 5, 2011, Pages 507-510
|
|
Clinical implications of leukocytapheresis using a centrifugal cell separator for steroid-resistant pyoderma gangrenosum associated with inflammatory bowel disease
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBODY;
C REACTIVE PROTEIN;
CHIMERA ANTIBODY;
CORTICOSTEROID;
CREATININE;
CYCLOSPORIN A;
DAPSONE;
GRANULOCYTE COLONY STIMULATING FACTOR;
INFLIXIMAB;
INTERLEUKIN 6;
NITROGEN;
PREDNISOLONE;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
UREA;
AGED;
BONE METASTASIS;
BREAST CANCER;
CANCER MORTALITY;
CASE REPORT;
CELL SEPARATION;
CENTRIFUGAL CELL SEPARATOR;
CENTRIFUGATION;
CREATININE BLOOD LEVEL;
DISEASE DURATION;
DISEASE EXACERBATION;
DRUG DOSE INCREASE;
DRUG DOSE REDUCTION;
ENTERITIS;
EPITHELIZATION;
ERYTHEMA;
FEMALE;
GASTROINTESTINAL ENDOSCOPY;
HISTOLOGY;
HORMONE RESISTANCE;
HOSPITAL ADMISSION;
HUMAN;
HUMAN TISSUE;
INJECTION SITE ABSCESS;
LETTER;
LEUKAPHERESIS;
LEUKOCYTE COUNT;
LIVER METASTASIS;
LOW BACK PAIN;
MASTECTOMY;
NEUTROPHIL CHEMOTAXIS;
PARENTERAL NUTRITION;
PROTEIN BLOOD LEVEL;
PYODERMA GANGRENOSUM;
RECURRENT DISEASE;
RELAPSE;
REMISSION;
SKIN ABSCESS;
SKIN BIOPSY;
SKIN INDURATION;
SKIN ULCER;
STERNUM;
TREATMENT DURATION;
TREATMENT RESPONSE;
UNSPECIFIED SIDE EFFECT;
UREA NITROGEN BLOOD LEVEL;
AGED;
CENTRIFUGATION;
DRUG RESISTANCE;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INFLAMMATORY BOWEL DISEASES;
LEUKAPHERESIS;
PYODERMA GANGRENOSUM;
STEROIDS;
TREATMENT OUTCOME;
|
|
EID: 79955393603
PISSN: 03852407
EISSN: 13468138
Source Type: Journal
DOI: 10.1111/j.1346-8138.2010.01009.x Document Type: Letter |
|
Times cited : (6)
|
|
References (10)
|
